share_log

CVS Health | 4: Statement of changes in beneficial ownership of securities-Officer Chaguturu Sreekanth K

SEC announcement ·  Feb 28 22:49
Summary by Moomoo AI
CVS Health EVP and Chief Medical Officer, Chaguturu Sreekanth K, completed a sale of 355 shares of common stock on February 26, 2024. The transaction was carried out at a price of $76.43 per share, resulting in a total value of $27,132.65. Following the sale, Chaguturu Sreekanth K's direct holdings in CVS Health amounted to 9,333.9847 shares. The sale was executed as a means to cover the exercise price or tax liability by delivering or withholding securities, as indicated by the transaction code 'F'.
CVS Health EVP and Chief Medical Officer, Chaguturu Sreekanth K, completed a sale of 355 shares of common stock on February 26, 2024. The transaction was carried out at a price of $76.43 per share, resulting in a total value of $27,132.65. Following the sale, Chaguturu Sreekanth K's direct holdings in CVS Health amounted to 9,333.9847 shares. The sale was executed as a means to cover the exercise price or tax liability by delivering or withholding securities, as indicated by the transaction code 'F'.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more